UNSPSC 51371702: Opium

This classification denotes a natural product and the source of many narcotic analgesics, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 37M3MZ001L. European Medicines Agency schedules Opium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Indices SUB12190MIG, SUB14698MIG, SUB14699MIG, SUB14700MIG, SUB14701MIG, SUB14702MIG, SUB14703MIG, SUB29028, and SUB61961.. As of Q4 2014, OPIUM remains the US FDA Preferred Term for this commodity. SMILES: O1C2C(OC)C(C(CCN(C)C)CC2OC1)CC(=O)C1C(C(OC)C(OC)CC1)C(=O)O.

UNSPSC 51371702 Opium is a Commodity code that in recent state and local procurement activity covers the supply of naloxone, pharmaceutical products, and over-the-counter medications to public health and human services agencies rather than opium itself. The work being solicited includes naloxone distribution systems for emergency response and overdose reversal, generic multi-source pharmaceutical supply through cooperative purchasing arrangements, and direct-to-manufacturer prescription fulfillment programs. Issuing bodies range from county health departments to state health and human services commissions and multistate cooperative purchasing alliances. Seminole County, Florida solicited naloxone and drug deactivation systems through competitive bidding; the Texas Health and Human Services Commission issued an RFI to explore direct-to-manufacturer prescription programs; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) administered by the Minnesota Department of Administration's Office of State Procurement opened a multi-vendor RFP for generic pharmaceuticals and OTC products across participating state and local government facilities including Oregon.

Recent activity concentrates in Florida, Texas, and Minnesota. The Seminole County IFB (Solicitation Number IFB60459723LAS, due July 26, 2023) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with shipping included in vendor pricing. The Texas HHS Commission's RFI (HHS0017013, posted April 3, 2026) was exploratory, gathering vendor capabilities on direct contracts with manufacturers outside traditional pharmacy benefit manager, group purchasing organization, and wholesaler arrangements. The MMCAP RFP (S1070000015802, due March 26, 2026) established multiple contracts for generic pharmaceuticals and OTC products distributed through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health, and Morris & Dickson Co., LLC—with awards effective July 1, 2026, and evaluation weighted 75 percent on price competitiveness, 10 percent on fixed pricing, and the remainder on administrative and operational compliance factors including cGMP and Drug Supply Chain Security Act certification.